Remove Marketing Remove Medicine Remove Research Remove Research Analyst
article thumbnail

Outsourcing Antibody Discovery Process: The Profit-Driven Approach to Research

Roots Analysis

These experts are like the superhero squad for medical research. This helps to speed up the process of making new medicines and finding cures for diseases. With the rising demand for antibody therapeutics in the recent past, the domain of antibody discovery has seen a significant market growth towards outsourcing.

article thumbnail

Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding

The Pharma Data

The drugmakers lost out to domestic producers, which in some cases undercut prices for established medicines by more than 90%, according to Jiemian. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. Virtual Event. DEVELOP A UNIFIED SCIENTIFIC VOICE.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Outsourcing Peptide Synthesis: Preferred Choice of Drug Developers

Roots Analysis

The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

In 2019, Cablivi became the first FDA-approved , nanobody-based medicine for acquired thrombotic thrombocytopenic purpura (aTTP), an ultra-orphan condition that causes blood clots in small blood vessels around the body. The disorder has a reported annual incidence between 1.5 cases per million in Europe.

article thumbnail

BioSpace Movers & Shakers, Jan. 1

The Pharma Data

Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,

article thumbnail

Novotech Health Holdings Appoints Zidong Zhang as CFO

The Pharma Data

28, 2020 /PRNewswire/ — Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist contract research organization (CRO) in Asia , today announced the appointment of Zidong Zhang as Chief Financial Officer (CFO) effective 4 January 2021. SHANGHAI and SYDNEY , Dec.